comprehensive -WSS

comprehensive

author：leisure time 2025-08-26 07:45:14 - browse：365

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Sports medicine is finally prioritizing gender equality
Next article： The Karikó problem: Lessons for funding basic research

focus

WSS

New oral drug delivery patch is modeled after octopus tentacles

WHO recommends second malaria vaccine

Setback for rare diseases as Taysha Gene Therapies pulls back

Radiology is caught between AI's potential and concern for patients

Lawsuit highlights wrinkle for disputes over surprise medical bills

The United States is paying nearly triple for new Covid vaccines

knowledge

comprehensive

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pharma patents targeted by Biden in move to slash drug prices

Moonlake's readout produced a cash windfall. Risks remain

AI models in health care face new federal disclosure requirements

BioMarin wins approval for gene therapy to treat hemophilia A

WHO recommends second malaria vaccine

ChatGPT in medicine: STAT answers readers' burning questions

Stop Congress from blocking public access to science

How to save PrEP access — and even expand it

The woman behind the Dana Farber

hotspot

Pfizer plans to depart BIO

Radiology is caught between AI's potential and concern for patients

Pharma patents targeted by Biden in move to slash drug prices

Radiology is caught between AI's potential and concern for patients

CDC picks Alphabet's Verily for wasterwater surveillance contract

Stop Congress from blocking public access to science

focus

focus

knowledge

hotspot